Egypt's Cabinet approves amendments to North Zafarana oil development agreement    Gold prices in Egypt slip on Thursday, 20 Nov., 2025    IMF officials to visit Egypt from 1–12 Dec. for fifth, sixth reviews: PM    Al-Sisi, Putin mark installation of reactor pressure vessel at Egypt's first Dabaa nuclear unit    Egypt, Angola discuss strengthening ties, preparations for 2025 Africa–EU Summit in Luanda    Gaza accuses Israel of hundreds of truce violations as winter rains deepen humanitarian crisis    Egypt concludes first D-8 health ministers' meeting with consensus on four priority areas    Egypt, Switzerland's Stark partner to produce low-voltage electric motors    Egypt explores industrial cooperation in automotive sector with Southern African Customs Union    Deep Palestinian divide after UN Security Council backs US ceasefire plan for Gaza    Egypt scraps parliamentary election results in 19 districts over violations    Health minister warns Africa faces 'critical moment' as development aid plunges    Egypt's drug authority discusses market stability with global pharma firms    Egypt extends Ramses II Tokyo Exhibition as it draws 350k visitors to date    Egypt signs host agreement for Barcelona Convention COP24 in December    Al-Sisi urges probe into election events, says vote could be cancelled if necessary    Filmmakers, experts to discuss teen mental health at Cairo festival panel    Cairo International Film Festival to premiere 'Malaga Alley,' honour Khaled El Nabawy    Cairo hosts African Union's 5th Awareness Week on Post-Conflict Reconstruction on 19 Nov.    Egypt golf team reclaims Arab standing with silver; Omar Hisham Talaat congratulates team    Egypt launches National Strategy for Rare Diseases at PHDC'25    Egypt's Al-Sisi ratifies new criminal procedures law after parliament amends it    Egypt adds trachoma elimination to health success track record: WHO    Egypt, Sudan, UN convene to ramp up humanitarian aid in Sudan    Grand Egyptian Museum welcomes over 12,000 visitors on seventh day    Sisi meets Russian security chief to discuss Gaza ceasefire, trade, nuclear projects    Grand Egyptian Museum attracts 18k visitors on first public opening day    'Royalty on the Nile': Grand Ball of Monte-Carlo comes to Cairo    Egypt launches Red Sea Open to boost tourism, international profile    Omar Hisham Talaat: Media partnership with 'On Sports' key to promoting Egyptian golf tourism    Sisi expands national support fund to include diplomats who died on duty    Egypt's PM reviews efforts to remove Nile River encroachments    Egypt will never relinquish historical Nile water rights, PM says    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



GSK says Ebola vaccine development progressing at 'unprecedented rate'
Mega pharmaceutical companies are racing against time in an effort to produce an Ebola vaccine
Reuters Published in Ahram Online on 19 - 10 - 2014

Britain's biggest drugmaker GlaxoSmithKline said on Saturday work to develop a vaccine to combat Ebola, which has killed thousands in West Africa, was moving at a rapid pace.
"Development of the vaccine candidate is progressing at an unprecedented rate, with first phase 1 safety trials with the vaccine candidate underway in the USA, UK and Mali, and further trials due to start in the coming weeks," the firm said in a statement posted on its website.
The company said preliminary data from the trials was expected by the end of 2014 and that, if successful, the next phase, involving the vaccination of frontline healthcare workers in Sierra Leone, Guinea and Liberia, would begin in early 2015.
The worst Ebola outbreak on record has killed more than 4,500 people so far, most in the trio of West African countries. In August, GSK said the experimental vaccine was being fast-tracked into human studies and it planned to build a stockpile of up to 10,000 doses for emergency deployment, if results were good.
The GSK vaccine consists of a common cold virus, called an adenovirus, engineered to carry two genes of the Ebola virus. Animal testing has shown that when the adenovirus infects cells the Ebola genes produce harmless proteins that stimulate the immune system to produce antibodies to Ebola.
GSK acquired the vaccine after buying Swiss-based biotech company Okairos for 250 million euros ($319 million) last year. Responding to public fears after three diagnosed cases in the United States, President Barack Obama urged Americans on Saturday not to give in to "hysteria" about the hemorrhagic fever, which is spread through the blood, sweat or vomit of those infected.
There is no cure or approved vaccine yet for Ebola but several pharmaceutical companies have been working on experimental drugs.
http://english.ahram.org.eg/News/113411.aspx

Clic here to read the story from its source.